Anthony Mancini

Anthony Mancini is an experienced executive in the pharmaceutical and healthcare sectors, currently serving as the Chief Global Commercialization Officer at Revolution Medicines since April 2025. Prior to this role, Mancini held the position of Executive Vice President and Chief Operating Officer at Genmab from March 2020 to March 2025. Mancini's significant tenure at Bristol-Myers Squibb from September 2012 to March 2020 involved multiple senior leadership roles, including SVP for Innovative Medicines and SVP for Cardiovascular in the US and Puerto Rico/Caribbean regions, along with managing directorial responsibilities in Australia and New Zealand. Earlier in the career, Mancini worked as a Consumer & Professional Relations Associate at McNeil Consumer Healthcare from January 1995 to June 1996. Academic qualifications include a General Management Program from INSEAD and an MBA in International Management from Clemson University.